document.writeln('<DIV style="flex=da; margin-top: 0px;  margin-right: 0px; margin-bottom: 0px; margin-left: 0px; "><FONT  class="Apple-style-span" color="#006A9D" face="Tahoma"  size="4"><SPAN class="Apple-style-span" style="flex=da; font-size:  14px;"><B>Curriculum Vitae</B></SPAN></FONT><SPAN class="Apple-tab-span" style="flex=da; white-space:pre">	</SPAN><FONT class="Apple-style-span"  color="#006A9D" face="Tahoma" size="4"><SPAN  class="Apple-style-span" style="flex=da; font-size: 14px;"><B> Professor  Lisbeth  Illum</B></SPAN></FONT></DIV><DIV style="flex=da; margin-top: 0px;  margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal  normal normal 12px/normal Helvetica; min-height: 14px; "><FONT  class="Apple-style-span" color="#006A9D"><BR></FONT></DIV><DIV  style="flex=da; margin-top: 0px; margin-right: 0px; margin-bottom: 0px;  margin-left: 0px; font: normal normal normal 11px/normal Helvetica;  min-height: 13px; "><BR></DIV><DIV style="flex=da; margin-top: 0px;  margin-right: 0px; margin-bottom: 0px; margin-left: 0px; "><FONT  class="Apple-style-span" color="#006AA5" face="Tahoma"  size="3"><SPAN class="Apple-style-span" style="flex=da; font-size:  13px;">Professor Lisbeth Illum was the founder and for 12 years the  Managing Director of DanBioSyst UK Ltd. (now Archimedes Ltd), a company  that specialised in development of Drug Delivery Systems.  She was the  Managing Director of Phaeton Research Ltd. and is Director of IDentity,  a consultancy company. She is also associated with Nottingham University  as a Special Professor where she supervises several postgraduate  students. </SPAN></FONT></DIV><DIV style="flex=da; margin-top: 0px;  margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal  normal normal 13px/normal Tahoma; min-height: 16px; "><FONT  class="Apple-style-span" color="#006AA5"><BR></FONT></DIV><DIV  style="flex=da; margin-top: 0px; margin-right: 0px; margin-bottom: 0px;  margin-left: 0px; "><FONT class="Apple-style-span" color="#006AA5"  face="Tahoma" size="3"><SPAN class="Apple-style-span"  style="flex=da; font-size: 13px;">She was awarded her M. Pharm, Ph. D and D.Sc.  from the Royal Danish School of Pharmacy in 1972, 1978 and 1988,  respectively.  Her research expertise covers the areas of novel drug  delivery systems for difficult drugs such as polar small molecular  weight compounds and peptides and proteins.  She has studied novel  approaches to delivery of such drugs using transmucosal routes such as  the nasal, the oral and the vaginal. </SPAN></FONT></DIV><DIV  style="flex=da; margin-top: 0px; margin-right: 0px; margin-bottom: 0px;  margin-left: 0px; font: normal normal normal 13px/normal Tahoma;  min-height: 16px; "><FONT class="Apple-style-span"  color="#006AA5"><BR></FONT></DIV><DIV style="flex=da; margin-top: 0px;  margin-right: 0px; margin-bottom: 0px; margin-left: 0px; "><FONT  class="Apple-style-span" color="#006AA5" face="Tahoma"  size="3"><SPAN class="Apple-style-span" style="flex=da; font-size:  13px;">She has published more than 300 scientific papers (is among the  top 100 most cited scientists on pharmacology) and has co-edited four  books including "Peptide Drug Delivery Systems" published by Plenum  Press, 1986.  She has filed nearly fifty patens on novel drug delivery  systems.  She has been awarded the title of "Docent" in the Royal  Danish School of Pharmacy and has been the recipient of several  scientific awards, latest the Eurand Career Achievement Award 2007.   She has been elected a Fellow of the AAPS and is presently the President  Elect of the CRS.  She has lectured throughout the world at  conferences and workshops.  She is on the Editorial Boards of seven  scientific journals and is a consultant to several multinational  pharmaceutical companies.</SPAN></FONT></DIV><BR>');
